Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 51655-933

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 51655-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-933-04 (51655 933 04 Rev A 10 22)

51655-933-04 (51655 933 04   Rev A 10 22)
Label for Ondansetron Tablets USP 4 mg, film-coated tablets, 4 count, prescription only. The label includes storage instructions to keep the product between 20°-25°C and protect from light. Manufactured by Northwind Pharmaceuticals and repackaged by Northwind Health Company, LLC in Indianapolis, IN.*
FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure of Ondansetron Hydrochloride dihydrate. The diagram shows the molecular connectivity, including the indole-like structure, ketone, methyl groups, and the hydrochloride with two water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.